Thermo Fisher Scientific introduces PPD CorEvitas Vitiligo Registry to advance real-world evidence in nonsegmental vitiligo
Real-world evidence registry for nonsegmental vitiligo to track long-term treatment outcomes and patient experiences
Real-world evidence registry for nonsegmental vitiligo to track long-term treatment outcomes and patient experiences
InstaFlux™ enables on-demand enrichment media preparation to streamline food microbiology testing workflows
As testing demands grow, food microbiology laboratories are rethinking labor-intensive media preparation workflows to improve efficiency, consistency, and productivity
Thermo Fisher’s presence at ADLM 2026 reflects its ongoing commitment to addressing unmet clinical needs with reliable, purpose-built diagnostic and workflow solutions
As Gram-negative resistance becomes more complex, laboratories and clinicians are working together to turn susceptibility data into more targeted treatment decisions
New GENESYS™ G5 series combines UV-Vis performance, expandable software packages, workflow flexibility, and compliance-ready data management for routine and advanced laboratory analysis
Screening tools are becoming vital in the fight against Candida auris, a rapidly spreading and deadly fungal infection with growing antifungal resistance
Digital platform improves quality control visibility and decision-making in clinical labs
Enhanced antibody detection supports more informed transplant matching decisions
New registry will generate robust real-world evidence on disease burden, treatment patterns, and long-term effectiveness of newly approved and emerging therapies
Compact centrifuge systems combine high performance with energy efficiency and next-generation refrigerant technology
New Orbitrap platforms, AI-enabled software and integrated workflows deliver deeper insight, more confident development decisions and stronger results across complex scientific markets
New mass spectrometry platforms, combined with AI-driven analytics and scalable proteomics solutions, help scientists turn complex biology into actionable insights across research and drug development
New Gibco™ CTS™ DynaXS™ single use bioreactor platform enables controlled, cGMP‑ready cell expansion from development through commercialization
A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible results
Equipped with the READY System to make structural biology research accessible to more labs
In this guest editorial, Richard Knight Senior Director, Medical Affairs, Thermo Fisher Scientific, explores how success in transplantation is measured in years, not hours, and how lab professionals provide the critical data needed to navigate the high-stakes journey of post-operative care
In this guest editorial, Jon Sherlock, Senior Director, Product Management at Thermo Fisher Scientific explores why supporting laboratory professionals is the key to bridging the gap between innovation and patient outcomes
Provides an automated, functionally closed approach to help address variability and support more reliable, consistent manufacturing outcomes
Integrated cell line development platform enables biologics developers to accelerate time to clinic while maintaining regulatory confidence and commercial scalability
By offering shared access to instrumentation and experienced cryo-EM scientists, the center allows companies to evaluate and incorporate the technology into existing workflows without building the infrastructure in-house
Multiplex PCR assay enables beverage microbiology labs to accelerate product release testing by up to six days
Brilliance Candida 2 Agar and Spectra Candida Agar support earlier detection, faster outbreak response and more informed treatment decisions in healthcare settings*
TacroType™ Pharmacogenetic Test designed to support more personalized tacrolimus dosing, assisting clinical decision-making in solid organ transplant recipients
Kit enables genomic, transcriptomic and proteomic analysis from a single sample to support cancer and disease research